Activated Charcoal Arabica Coffee Bean Causticum E
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
- Activated Charcoal Arabica Coffee Bean Causticum E
- Multi-Component Herbal Formula: Insufficient Data for Repurposing Evaluation
Multi-Component Herbal Formula: Insufficient Data for Repurposing Evaluation
One-Sentence Summary
This submission describes a multi-component formula comprising eight ingredients — including Activated Charcoal, Arabica Coffee Bean, Causticum, Eleuthero, Glycyrrhiza Glabra, Prasterone, Ribes Nigrum Flower Bud, and Veratrum Album Root — with no approved indication on record in Taiwan. The TxGNN model returned no predicted new indications for this compound entry, and no supporting clinical trials or publications were identified for evaluation. Without a DrugBank anchor or a recognized INN-level identity, the evidence pipeline could not generate a scorable candidate.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | No approved indication on record |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (no supporting studies identified) |
| Market Status | Not marketed in Taiwan |
| Number of Approvals | 0 |
| Recommended Decision | Hold |
Why No Prediction Was Generated
The TxGNN pipeline requires a resolvable DrugBank ID to anchor a drug within the knowledge graph. For this submission, the query string contained eight heterogeneous ingredients simultaneously, including:
- A physical adsorbent (Activated Charcoal)
- A botanical adaptogen (Eleuthero / Eleutherococcus senticosus)
- A licorice root extract (Glycyrrhiza glabra)
- A steroid hormone precursor (Prasterone / DHEA)
- Two homeopathic dilutions (Causticum, Veratrum Album Root)
- A berry bud extract (Ribes Nigrum Flower Bud)
- A caffeinated botanical (Arabica Coffee Bean)
This formulation does not correspond to a single recognized INN or a named fixed-dose combination registered in any major pharmacopoeia. As a result, no DrugBank ID was resolved, the knowledge graph could not assign a node, and TxGNN produced no output.
The combination also presents a pharmacological heterogeneity problem: the ingredients span at least four mechanistic classes (adsorption, hormonal modulation, adaptogenic activity, homeopathic dilution), making any unified mechanism-of-action analysis impractical with current tools.
Clinical Trial Evidence
Currently no related clinical trials registered for this multi-component entry as a combined formulation.
Literature Evidence
Currently no related literature available for this multi-component entry as a combined formulation.
Safety Considerations
Please refer to the package insert for safety information.
Note for reviewers: Veratrum album root contains steroidal alkaloids (jervine, cyclopamine) that are highly toxic in non-diluted forms. Even in homeopathic preparations, any formulation containing this ingredient should undergo a dedicated toxicological review before any repurposing assessment proceeds.
Conclusion and Next Steps
Decision: Hold
Rationale: The evidence pipeline could not evaluate this submission because the multi-ingredient query string does not resolve to a single pharmacological entity; without a DrugBank node, TxGNN has no basis for prediction, and no existing indication or safety profile exists in the Taiwan registry.
To proceed, the following is needed:
- Decompose the formula: Submit each of the eight ingredients as separate, INN-level queries so the TxGNN pipeline can evaluate each component individually against the knowledge graph.
- Establish a primary active ingredient: Identify which ingredient is the therapeutic driver (e.g., Prasterone / DHEA or Glycyrrhiza glabra extract) and build the repurposing case around that single agent.
- Resolve a DrugBank ID: At minimum for Prasterone (DB01708), Eleuthero, and Glycyrrhiza glabra, which each have structured entries that support KG traversal.
- Toxicological review for Veratrum Album: Before any clinical or regulatory pathway is explored, an independent safety review of Veratrum album root content and dose is required.
- Clarify regulatory classification: Determine whether this formula is intended as a pharmaceutical drug, dietary supplement, or homeopathic product — this classification determines which regulatory and evidence framework applies.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.